Literature DB >> 27601437

Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease.

Edward J Goetzl1,2, Dimitrios Kapogiannis3, Janice B Schwartz4,2,5, Iryna V Lobach6, Laura Goetzl7, Erin L Abner8, Gregory A Jicha8, Anna M Karydas9, Adam Boxer9, Bruce L Miller9.   

Abstract

Synaptic dysfunction occurs early in senile dementias, presumably as a result of decreased levels of functional synaptic proteins as found in autopsied brains of patients with Alzheimer's disease (AD) or frontotemporal dementia (FTD). Plasma neuronal-derived exosomes (NDEs) were recovered by precipitation and immunoabsorption from 12 patients with AD, 16 with FTD, and 28 controls in a cross-sectional study, and from 9 patients with AD, 10 with FTD, and 19 controls in a longitudinal study. Six synaptic proteins in NDE extracts were quantified by ELISAs and normalized for exosome amounts. NDE levels of synaptophysin, synaptopodin, synaptotagmin-2, and neurogranin were significantly lower in patients with FTD and AD than in controls, but those of growth-associated protein 43 and synapsin 1 were reduced only in patients with AD. Functionally relevant phosphorylation of synapsin 1 serine 9 was reduced in patients with FTD and AD, although total synapsin 1 protein was higher in FTD than in controls. NDE levels of synaptotagmin, synaptophysin, and neurogranin were decreased years before dementia in patients with FTD and AD. NDE levels of synaptopodin, synaptotagmin, and synaptophysin, but not of amyloid β-peptide 42 or P-T181-tau, were correlated significantly with cognition assessed by mini-mental state examination or AD assessment scale-cognitive subscale. NDE synaptic proteins may be useful preclinical indices and progression measures in senile dementias.-Goetzl, E. J., Kapogiannis, D., Schwartz, J. B., Lobach, I. V., Goetzl, L., Abner, E. L., Jicha, G. A., Karydas, A. M., Boxer, A., Miller, B. L. Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease. © FASEB.

Entities:  

Keywords:  biomarkers; cognition; neurotransmission; proteinopathy

Mesh:

Substances:

Year:  2016        PMID: 27601437      PMCID: PMC5102122          DOI: 10.1096/fj.201600816R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  35 in total

Review 1.  Normal development of brain circuits.

Authors:  Gregory Z Tau; Bradley S Peterson
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

2.  Classification of primary progressive aphasia and its variants.

Authors:  M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman
Journal:  Neurology       Date:  2011-02-16       Impact factor: 9.910

3.  Ca2+-dependent interaction of the growth-associated protein GAP-43 with the synaptic core complex.

Authors:  T Haruta; N Takami; M Ohmura; Y Misumi; Y Ikehara
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

4.  Neurogranin null mutant mice display performance deficits on spatial learning tasks with anxiety related components.

Authors:  T Miyakawa; E Yared; J H Pak; F L Huang; K P Huang; J N Crawley
Journal:  Hippocampus       Date:  2001       Impact factor: 3.899

5.  Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.

Authors:  Hlin Kvartsberg; Flora H Duits; Martin Ingelsson; Niels Andreasen; Annika Öhrfelt; Kerstin Andersson; Gunnar Brinkmalm; Lars Lannfelt; Lennart Minthon; Oskar Hansson; Ulf Andreasson; Charlotte E Teunissen; Philip Scheltens; Wiesje M Van der Flier; Henrik Zetterberg; Erik Portelius; Kaj Blennow
Journal:  Alzheimers Dement       Date:  2014-12-19       Impact factor: 21.566

6.  The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts.

Authors:  Stefan J Cano; Holly B Posner; Margaret L Moline; Stephen W Hurt; Jina Swartz; Tim Hsu; Jeremy C Hobart
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-09-29       Impact factor: 10.154

7.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

8.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.

Authors:  S T DeKosky; S W Scheff
Journal:  Ann Neurol       Date:  1990-05       Impact factor: 10.422

9.  X-linked intellectual disability-associated mutations in synaptophysin disrupt synaptobrevin II retrieval.

Authors:  Sarah L Gordon; Michael A Cousin
Journal:  J Neurosci       Date:  2013-08-21       Impact factor: 6.167

10.  Short-term synaptic plasticity is altered in mice lacking synapsin I.

Authors:  T W Rosahl; M Geppert; D Spillane; J Herz; R E Hammer; R C Malenka; T C Südhof
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

View more
  123 in total

Review 1.  (-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease.

Authors:  Robert E Becker; Nigel H Greig; Debomoy K Lahiri; Joseph Bledsoe; Sarah Majercik; Clive Ballard; Dag Aarsland; Lon S Schneider; Douglas Flanagan; Ramprakash Govindarajan; Mary Sano; Luigi Ferrucci; Dimitrios Kapogiannis
Journal:  Curr Alzheimer Res       Date:  2018       Impact factor: 3.498

Review 2.  Emerging roles of extracellular vesicles in neurodegenerative disorders.

Authors:  Yang You; Tsuneya Ikezu
Journal:  Neurobiol Dis       Date:  2019-06-20       Impact factor: 5.996

3.  CNS cell type-specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation.

Authors:  Yazi D Ke; Gabriella Chan; Kristie Stefanoska; Carol Au; Mian Bi; Julius Müller; Magdalena Przybyla; Astrid Feiten; Emmanuel Prikas; Glenda M Halliday; Olivier Piguet; Matthew C Kiernan; Michael Kassiou; John R Hodges; Clement T Loy; John S Mattick; Arne Ittner; Jillian J Kril; Greg T Sutherland; Lars M Ittner
Journal:  J Biol Chem       Date:  2019-07-31       Impact factor: 5.157

4.  High complement levels in astrocyte-derived exosomes of Alzheimer disease.

Authors:  Edward J Goetzl; Janice B Schwartz; Erin L Abner; Gregory A Jicha; Dimitrios Kapogiannis
Journal:  Ann Neurol       Date:  2018-03-10       Impact factor: 10.422

5.  Polyglutamylation of tubulin's C-terminal tail controls pausing and motility of kinesin-3 family member KIF1A.

Authors:  Dominique V Lessard; Oraya J Zinder; Takashi Hotta; Kristen J Verhey; Ryoma Ohi; Christopher L Berger
Journal:  J Biol Chem       Date:  2019-02-15       Impact factor: 5.157

6.  Synaptic and complement markers in extracellular vesicles in multiple sclerosis.

Authors:  Pavan Bhargava; Carlos Nogueras-Ortiz; Sol Kim; Francheska Delgado-Peraza; Peter A Calabresi; Dimitrios Kapogiannis
Journal:  Mult Scler       Date:  2020-06-17       Impact factor: 6.312

Review 7.  Extracellular Vesicles for Research on Psychiatric Disorders.

Authors:  Shin-Ichi Kano; Eisuke Dohi; Indigo V L Rose
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

8.  Brain insulin resistance and altered brain glucose are related to memory impairments in schizophrenia.

Authors:  S Andrea Wijtenburg; Dimitrios Kapogiannis; Stephanie A Korenic; Roger J Mullins; Joyce Tran; Frank E Gaston; Shuo Chen; Maja Mustapic; L Elliot Hong; Laura M Rowland
Journal:  Schizophr Res       Date:  2019-02-11       Impact factor: 4.939

9.  Extracellular vesicles reveal abnormalities in neuronal iron metabolism in restless legs syndrome.

Authors:  Sahil Chawla; Seema Gulyani; Richard P Allen; Christopher J Earley; Xu Li; Peter Van Zijl; Dimitrios Kapogiannis
Journal:  Sleep       Date:  2019-07-08       Impact factor: 5.849

10.  Neuronal Enriched Extracellular Vesicle Proteins as Biomarkers for Traumatic Brain Injury.

Authors:  Hanuma Kumar Karnati; Joseph H Garcia; David Tweedie; Robert E Becker; Dimitrios Kapogiannis; Nigel H Greig
Journal:  J Neurotrauma       Date:  2018-10-25       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.